Aeterna Zentaris to Present at Upcoming Canaccord Genuity 35th Annual Global Growth Conference in Boston

QUÉBEC CITY, Aug. 4, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the Company's Chairman and CEO, David Dodd, will be presenting a corporate overview at the Canaccord Genuity 35th Annual Global Growth Conference on Wednesday, August 12, 2015, at 11 am (Eastern), in the Melbourne Room of the Intercontinental Hotel in Boston.

A live audio and slide webcast of the presentation will be available via the Company's website at in the "Newsroom" section, under "Events and Webcasts". A replay of the webcast will also be available on the Company's website for a period of 90 days.

About Aeterna Zentaris Inc.

Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. For more information, visit


SOURCE Aeterna Zentaris Inc.

For further information: Paul Burroughs, Director of Communications, (418) 652-8525 ext. 406,


Organization Profile

Aeterna Zentaris Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890